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The expression of cytokines may influence the development of lymphoma in retrovirally infected animals in at least two
ways: (1) cytokines in the tumor environment may stimulate the proliferation of tumor cells and/or (2) cytokines in the tumor
environment may diminish the cell-mediated antitumor immune response. To evaluate these possibilities, a semiquantitative
RT–PCR approach was utilized to permit a broad screening of cytokine mRNAs in a large number of tissue samples.
Examination of MuLV-induced end-stage lymphomas revealed the absence of mRNA for cytokines known to stimulate the
proliferation of T cells (i.e., IL-2, IL-9), the absence of mRNA for cytokines known to enhance cell-mediated antitumor immune
responses (i.e., IL-2, IFNg), and the presence of mRNA for cytokines known to diminish such responses (i.e., IL-4, IL-10).
Similar patterns of cytokine mRNA expression were detected in tumor-derived cell lines. Spleen and thymus from animals
collected longitudinally during infection and from age-matched uninfected mice also demonstrated a similar pattern, except
that IFNg mRNA was readily detectable. These findings do not support the hypothesis that the developing tumor depends
on cytokines to provide proliferative signals. The findings suggest that cytokines in the immediate environment of the
lymphoma support tumor development by acting to diminish an effective antitumor immune response. © 1999 Academic Press
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The nonacute murine and feline leukemia viruses
MuLV; FeLV) lack an oncogene within the genome, yet
redictably induce lymphoid or other hematopoietic ma-
ignancy in the natural host. The basis for susceptibility
f the host to virus-induced malignant change is not
ntirely understood, although it clearly involves multiple
irus- and host-encoded determinants (Athas et al., 1994;
an, 1997). MuLV- or FeLV-transformed lymphocytes ex-
ress viral antigens on the cell surface, yet they success-
ully evade immune destruction and proliferate rapidly to
orm tumors of considerable size. The mechanisms by
hich these cells avoid immune detection and/or de-
truction are thought to involve both the alteration of viral
ntigens to avoid immune recognition, and virus-induced
odulation of the host immune response to infection
Marshall and Gaulton, 1996).
In general, the susceptibility of the natural host to
uLV- or FeLV-induced lymphoma is age dependent and
estricted largely to the neonatal period. The basis for
ncreased susceptibility of the neonate to retrovirally
nduced lymphoma is not clearly understood; however,
1 Present address: Department of Biology, University of North Caro-
ina, Charlotte, NC 28036.
2 To whom reprint requests should be addressed at Department of
icrobiology and Immunology, Tulane Medical School SL38, 1430
ulane Ave., New Orleans, LA 70112. Fax: (504) 588-5144. E-mail:
ulevy@tmcpop.tmc.tulane.edu.
253n important recent study has advanced our understand-
ng of neonatal susceptibility to retroviral infection (Sar-
otti et al., 1996). In that study, newborn mice were
noculated with Cas-Br-M MuLV in high doses sufficient
o induce virus replication in the spleen and brain and
onsequent neurological disease. Splenocytes removed
rom such animals were shown to produce significant
mounts of interleukin-4 (IL-4) after antigen restimulation
n culture, but neither interferon-gamma (IFN-g) produc-
ion nor an antigen-specific CTL response could be elic-
ted. Thus although the newborns responded immuno-
ogically to the inoculum, a nonprotective Th2-type im-
une response was induced. When animals were
noculated with very low doses of virus, in contrast, the
solated splenocytes produced both IFN-g and a CTL
esponse, but not IL-4, after antigen restimulation. Thus a
rotective Th1-type response was induced after inocula-
ion of a low virus dose. These findings indicate that the
ewborn is indeed immunologically responsive to retro-
iral infection and that the initial virus dose is a critical
eterminant of a protective immune response. The find-
ngs represent a paradigm shift because they challenge
he widely held assumption that neonatal susceptibility
o MuLV infection reflects nonresponsiveness due either
o immunological immaturity of the newborn animal
nd/or the induction of immunological tolerance (Sarzotti
t al., 1996).
Comparable studies have not been performed to eval-
ate the immune response to neonatal inoculation with
0042-6822/99 $30.00
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254 BEATY ET AL.ymphomagenic retroviruses. Indeed, little information is
vailable about the nature or impact of the cytokine
esponse in MuLV-mediated lymphomagenesis. In view
f the finding that newborn mice were not tolerized
gainst Cas-Br-M MuLV infection but rather may have
neffective Th2 responses (Sarzotti et al., 1996), the need
o study the immune response to ongoing MuLV infection
nd lymphomagenesis is of increased interest. In partic-
lar, the levels of cytokine mRNAs have not been exam-
ned directly in lymphoma tissues. This is an important
nitial step in delineating the possible role of cytokines in
odulating the antitumor immune response to retrovi-
ally induced lymphoma. We and others have hypothe-
ized that cytokines expressed in the immediate environ-
ent of lymphoma may support its development and/or
aintenance in at least two ways (Hsu et al., 1993; Levy
nd Bost, 1996): (1) cytokines in the environment of the
umor, produced by the tumor itself or by neighboring
ells, may stimulate tumor cell proliferation and/or (2)
ytokines in the environment of the tumor, produced by
he tumor itself or by neighboring cells, may influence the
ell-mediated immune response in a manner deleterious
o expression of effective antitumor immunity. The objec-
ive of the present study was to evaluate the profile of
ytokine mRNAs expressed in the immediate environ-
ent of MuLV-induced lymphomas as a first step in
valuating their possible influence on tumor develop-
ent or survival. A semiquantitative RT–PCR approach
as utilized to permit a broad screening of a large
umber of samples. We first examined primary lym-
homa tissue directly. Tumor-derived cell lines also were
xamined, as were control tissues from age-matched,
ninfected animals, to evaluate the likely cellular origin
f cytokines in the tumor environment and to assess the
ossibility that the environment may be modulated by the
umor itself. Finally, cytokine mRNAs were examined
ongitudinally during infection in relevant tissues to eval-
ate the potential modulation of immune response dur-
ng chronic infection and tumor development.
RESULTS
-cell proliferative cytokines expressed in the tumor
nvironment
The goal of these studies was to examine the patterns
f cytokine mRNAs expressed in MuLV-induced lym-
homas. The T-cell lymphomas used for these studies
ere induced in NIH/Swiss mice by SL3–3 MuLV (SL3) or
y FS-LC MuLV (FS), a recombinant MuLV in which the
3 region of SL3 was replaced with that of a T-cell
ymphoma-derived FeLV provirus. FS was previously
hown to induce T-cell lymphomas with kinetics and
natomic distribution comparable with SL3 (Pantginis et
l., 1997). The approach used was to isolate RNA from
nd-stage lymphomas and to examine the profile of cy-okine mRNAs by RT–PCR. The assay for cytokine fRNAs was semiquantitative because the amount of
DNA used in each amplification reaction was normal-
zed for amplification of GAPDH mRNA and because the
eaction parameters were selected for detection of PCR
roducts outside the reaction plateau, i.e., within the
ange of increasing amplification.
As hypothesized above, one mechanism by which cy-
okines in the tumor environment may influence lym-
homagenesis is by providing a proliferative stimulus to
umor cells. For T-cell lymphomas, the cytokines most
nfluential in providing such a stimulus are likely to be
nterleukin 2 (IL-2) and interleukin 9 (IL-9). IL-2 is a
roduct of T lymphocytes that acts to promote the acti-
ation and growth of T cells in an autocrine or paracrine
anner (Hsu et al., 1993). IL-9, also a product of T cells,
s both a proliferative and an antiapoptotic factor for
alignant T lymphocytes (Vink et al., 1993; Renauld et al.,
995). Indeed, a fraction of transgenic mice overexpress-
ng IL-9 develop thymic lymphomas (Renauld et al., 1994).
s measured by RT–PCR, however, the levels of IL-2 and
L-9 mRNA are low or undetectable in the 18 lymphomas
xamined (Fig. 1). Thus these data do not support the
ypothesis that tumor cell proliferation is stimulated by
ytokines in the tumor environment. The absence of IL-9
s particularly interesting in light of previous studies of
ymphomas in the rat infected with Moloney murine leu-
emia virus. In that system, the acquisition of IL-2-inde-
endence by lymphoma-derived cell lines was associ-
ted with the upregulation of expression of both IL-9 and
ts receptor, IL-9R, thus establishing an autocrine loop.
he mechanism by which IL-9 expression is altered
emains unknown, but IL-9R upregulation was shown to
e secondary to its insertional activation by proviral DNA
Flubacher et al., 1994). To determine whether the IL-9R
ocus may be activated by provirus insertion in SL3- or
S- induced lymphomas, the structure of the IL-9R locus
as examined by Southern blot analysis using a cDNA
robe for IL-9R (Renauld et al., 1992). No evidence of
L-9R gene rearrangement was detected in any of the
ymphomas, using various restriction enzymes to visual-
ze .20 kb of the locus (data not shown).
ytokines in the tumor environment that may
nfluence the antitumor immune response
The working hypothesis, as delineated above, predicts
second mechanism by which cytokines in the tumor
nvironment may influence lymphomagenesis, i.e., by
iminishing or otherwise altering the cell-mediated anti-
umor immune response. To test this possibility, lympho-
as were examined for mRNA-encoding cytokines
nown to suppress an effective cell-mediated immune
esponse, specifically, interleukin 4 (IL-4) and interleukin
0 (IL-10). These cytokines, as products of Th2 lympho-
ytes, suppress cell-mediated immunity by inhibiting ef-ector cell activation and/or function, by limiting the pro-
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255CYTOKINES IN MuLV-MEDIATED LYMPHOMASuction of cytokines that augment the cell-mediated re-
ponse, and by supporting the development of a
onprotective humoral response (Cortes and Kurzrock,
997; Levy and Bost, 1996; Wojtowicz-Praga, 1997). Anal-
sis of SL3- and FS-induced lymphomas showed that
elatively high levels of IL-4 mRNA were present in most
ymphomas occurring in the spleen, although not in lym-
homas of the thymus (Fig. 1). In contrast, expression of
L-10 mRNA was clearly evident in all 18 lymphomas
xamined, regardless of the tissue of origin (Fig. 1).
Tumors then were examined for mRNA-encoding cy-
okines known to enhance an effective cell-mediated
mmune response, specifically, IL-2 and IFN-g. These
ytokines, as products of Th1 lymphocytes, support cell-
ediated immunity by augmenting a variety of responses
ncluding CTL activity, macrophage activation, and the
pregulation of MHC antigen expression (Levy and Bost,
996). As discussed above, IL-2 mRNA was notably ab-
ent from the tumor tissue in all samples examined.
FIG. 1. RT–PCR analysis of total cellular RNA isolated from lympho-
as of the spleen or thymus of NIH/Swiss mice infected with SL3 (S)
r FS-LC (FS) MuLV. Specific primer sets were used to amplify the
ytokine mRNA of interest, as indicated. GAPDH mRNA was amplified
s a control to normalize the amounts of cDNA in each cytokine
mplification reaction. Amplification conditions were selected such that
he reaction was monitored outside the plateau phase. Also shown are
reagent control from which cDNA template was omitted (2), and a
ositive control that included cDNA from PHA-stimulated mouse
pleen cells (1). The experiment shown is representative of at least
hree repetitions.xamination of the tumors revealed that IFNg mRNA was tenerally low or undetectable, particularly in tumors of
he spleen. IFNg mRNA was detectable in only two of six
ymphomas of the thymus (Fig. 1).
rofile of cytokine mRNA present in tumor-derived
ell lines
The data shown in Fig. 1 reveal a distinctive pattern of
ytokine expression in the environment of the end-stage
ymphoma; however, it is not evident from the findings
hether the cytokines derive from the tumor itself or from
urrounding normal tissue. To evaluate this question, we
btained a set of lymphoma-derived cell lines from AKR
ice that previously were found to produce SL3 or a
losely related ecotropic MuLV (SL3H, SL7H) or to pro-
uce recombinant viruses with polytropic env genes
SL11H, MCF247I) (Pedersen et al., 1982). Expression of
he cytokines of interest in those cell lines was examined
y RT–PCR for comparison with the lymphoma samples
Fig. 2). As was seen in the lymphomas, expression of
L-2 and IL-9 mRNA was low or undetectable in all cell
FIG. 2. RT–PCR analysis of total cellular RNA isolated from tumor-
erived cells lines SL3H (1), SL7H (2), SL11H (3), and MCF247I (4),
erformed as described in the legend to Fig. 1. Also shown are a
eagent control from which cDNA template was omitted (2), and a
ositive control that included cDNA from PHA-stimulated mouse
pleen cells (1). The experiment shown is representative of at leasthree repetitions.
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256 BEATY ET AL.ines. Expression of IFNg mRNA was variable as it was in
he lymphomas. Expression of IL-4 mRNA was low or
ndetectable, thus resembling lymphomas isolated from
he thymus rather than from the spleen. This finding is
onsistent with the origin of the cell lines from thymic
ymphomas (Pedersen et al., 1982). Curiously, IL-10
RNA is expressed in the cell lines that produce eco-
ropic viruses closely related to SL3 but not in those cell
ines that produce recombinant viruses with polytropic
nv genes. Perhaps some aspect of the mechanism of
umor induction during SL3 infection differs depending
n whether polytropic recombinants arise. Taken to-
ether, the findings demonstrate similarity between the
atterns of cytokine gene expression in tumors as com-
ared with tumor-derived cell lines.
rofile of cytokine mRNA present in uninfected
issues from age-matched animals
The observation that tumor-derived cell lines express
pattern of cytokine mRNA similar to that in the tumor
ass suggests the possibility that the developing tumor
ay modulate the immune environment in its immediate
urroundings through the expression of cytokines of the
ype observed. To evaluate this possibility, spleen and
hymus from age-matched, uninfected NIH/Swiss mice
ere obtained. Expression of the cytokines of interest in
hose tissues was examined by RT–PCR for comparison
ith the lymphoma samples (Fig. 3). The results demon-
trate that IL-2 mRNA is low or undetectable in normal
pleen and thymus of control animals of comparable
ge, an indication that the tumor does not depend on IL-2
n the target organ to provide a proliferative stimulus
uring its development. In contrast, IL-9 mRNA is readily
etectable in normal thymus of most animals. As shown
bove (Figs. 1 and 2), IL-9 mRNA is not generally evident
n the tumor-bearing thymus or in tumor-derived cell
ines. Thus its absence in the tumor environment may be
consequence of tumor development. Similarly, IFNg
RNA is also readily detectable in the spleen and thy-
us of most control animals, although its expression in
umors is significantly lower. This modification in the
ytokine environment is predicted to support tumor de-
elopment because the presence of IFNg could promote
n effective, Th1-type antitumor immune response (Levy
nd Bost, 1996). IL-10 mRNA is also readily detectable in
ninfected tissues from control animals, the presence of
hich may further provide a hospitable environment for
he developing tumor by acting to diminish an effective
ntitumor immune response.
xpression of IL-2, IFN-g, and IL-10 mRNA in target
issues longitudinally during infection
Examination of cytokine mRNAs in end-stage lympho-
as, while revealing, represents only a single time pointuring MuLV infection and tumorigenesis. To examine The possible modulation of cytokine mRNA expression
ongitudinally during infection in tissues in which tumors
rise, spleen and thymus were collected from SL3-in-
ected mice periodically after infection. SL3 was utilized
or longitudinal studies, rather than FS, because tumors
ccur in SL3-infected NIH/Swiss mice uniformly over
0–75 days. In FS- infected mice, in contrast, tumors
rise over a broader time period between 60–120 days
Pantginis et al., 1997). Thus infection with SL3 is useful
or a longitudinal study of this type because the disease
rogresses relatively uniformly in all infected animals.
efore examining cytokine mRNA expression longitudi-
ally during infection, it was first necessary to demon-
trate the presence of replicating SL3 in the spleen and
hymus of infected animals at the selected time points.
eonatal NIH/Swiss mice were inoculated intraperitone-
lly with SL3, and tissues were collected at 1, 2, 4, 6, and
weeks p.i. Genomic DNA was isolated from the tissues,
nd SL3 proviral DNA was detected by PCR amplification
sing oligonucleotide primers specific for the SL3 LTR.
FIG. 3. RT–PCR analysis of total cellular RNA isolated from the
pleen and thymus of five uninfected NIH/Swiss mice, age-matched to
ymphoma-bearing animals, performed as described in the legend to
ig. 1. Also shown are a reagent control from which cDNA template was
mitted (2), and a positive control that included cDNA from PHA-
timulated mouse spleen cells (1). The experiment shown is repre-
entative of at least three repetitions.he results of this analysis revealed the presence of SL3
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257CYTOKINES IN MuLV-MEDIATED LYMPHOMASroviral DNA in spleen and thymus, beginning at 2
eeks p.i. (Fig. 4).
Having demonstrated the presence of SL3 in the tis-
ues of interest, RNA from spleen and thymus collected
t 1, 2, 4, and 8 weeks p.i. then was examined by RT–PCR
or expression of cytokine mRNAs. IL-2 and IFN-g mRNA
ere examined as representative of the type 1 response,
nd IL-10 mRNA was examined as representative of the
ype 2 response. The expression of IL-2 mRNA was
aintly detectable in the spleen and thymus of SL3-in-
ected animals throughout the time course examined and
id not differ appreciably from levels detected in age-
atched uninfected tissues. Thus there is little apparent
ncrease in the level of IL-2 mRNA in spleen or thymus
FIG. 4. PCR analysis of SL3 proviral DNA present in spleen and
hymus of NIH/Swiss mice inoculated with virus as neonates. Tissue
amples were collected at various times after infection between 1 and
weeks, as indicated. Genomic DNA (1 mg) from each sample was
xamined for SL3 provirus using PCR primers specific for the SL3 LTR
SL3). Parallel reactions were conducted using GAPDH primers as a
ontrol for amplifiable DNA. The data shown are representative of four
nimals examined at each time point. Also shown is amplification of
enomic DNA from age-matched uninfected control animals using
L3-specific primers, or using GAPDH primers, to demonstrate that the
L3 primers do not amplify a product from uninfected control animals
UC).uring the course of infection with SL3 (Fig. 5). In con- Prast, IFN-g mRNA was readily detectable in the spleen
nd thymus of SL3-infected animals, particularly by 2
eeks p.i. IFN-g mRNA was also detectable in age-
atched tissues from uninfected animals, but at lower
evels, particularly in the thymus (Fig. 6). Thus an in-
rease in IFN-g mRNA occurs in the spleen and thymus
s a consequence of infection and apparently reflects an
nti-viral type 1 immune response at early times postin-
ection. The expression of IL-10 mRNA was readily de-
ectable in spleen and thymus samples throughout the
ime course examined, increasing between 1 and 2
eeks p.i. IL-10 mRNA levels in infected tissues were
enerally comparable with those in age-matched unin-
ected controls (Fig. 7). Thus no increase is evident in
L-10 mRNA levels in response to viral infection; how-
ver, endogenous expression of IL-10 mRNA is clearly
vident in tissues targeted for tumor development.
DISCUSSION
The objective of the present study was to evaluate the
rofile of cytokine gene expression in the immediate
nvironment of MuLV-induced lymphomas with empha-
is on cytokines known to influence the cell-mediated
FIG. 5. . RT–PCR analysis of IL-2 mRNA in the spleen and thymus of
L3-infected animals (SL3) collected at 1, 2, 4, or 8 weeks p.i. or in
ge-matched uninfected controls (UC). Specific primer sets were used
o amplify IL-2 mRNA or GAPDH mRNA. Amplification conditions were
elected such that the reaction was monitored outside the plateau
hase. The results from analysis of three animals at each timepoint are
hown. Also shown are a reagent control from which cDNA template
as omitted (2), and a positive control that included cDNA from
HA-stimulated mouse spleen cells (1). ND, not done.
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258 BEATY ET AL.mmune response. The use of RT–PCR to examine cyto-
ine mRNA, rather than the protein product itself, permit-
ed the broad screening of a large number of tissue
amples. The RT–PCR approach utilized was semiquan-
itative, such that the results indicate relative levels of
ytokine mRNA in the tissue samples examined. In this
ontext, the results indicate that the environment of the
nd-stage, MuLV-induced lymphoma (i) lacks cytokines
hat are known to stimulate T-cell proliferation or that
romote cell-mediated immunity and (ii) contains cyto-
ines that diminish effective cell-mediated immune re-
ponses. In particular, the 18 end-stage lymphomas ex-
mined contain little or no mRNA encoding IL-2, IL-9, or
FNg; however, they contain high levels of mRNA encod-
ng IL-4 and IL-10. These observations are consistent
ith Biron’s proposed model (Biron, 1994) which sug-
ests that, late in chronic retroviral infection, a shift in the
mmune response occurs such that responses to spe-
ific antigen stimulation are predominantly of the Th2
ype.
The absence of mRNA encoding IL-2 or IL-9 in lym-
homas (Fig. 1) does not support the hypothesis that
umor-cell proliferation is stimulated by cytokines in the
FIG. 6. . RT–PCR analysis of IFN-g mRNA in the spleen and thymus
f SL3-infected animals (SL3) collected at 1, 2, 4, or 8 weeks p.i. or in
ge-matched uninfected controls (UC). Specific primer sets were used
o amplify IFN-g mRNA or GAPDH mRNA. Amplification conditions
ere selected such that the reaction was monitored outside the pla-
eau phase. The results from analysis of three animals at each time-
oint are shown. Also shown are a reagent control from which cDNA
emplate was omitted (2), and a positive control that included cDNA
rom PHA-stimulated mouse spleen cells (1). ND, not done.umor environment. The nature of the proliferative signal Pemains unknown. A possibility not investigated in the
resent study is that IL-15 may be present in the tumor
nvironment and would thereby be predicted to stimulate
umor-cell proliferation. IL-15 is a recently discovered
ytokine that shares biological activities with IL-2. IL-15
s important for normal lymphocyte development and for
he growth and differentiation of T-lymphocytes, among
ther cellular targets (He and Malek, 1998; Kirman et al.,
998). IL-15 expression is known to be regulated post-
ranscriptionally (Waldmann et al., 1998); thus the assay
ystem employed in the present study is not well suited
or analysis of IL-15 expression. In contrast to our find-
ngs, an IL-9 autocrine loop is hypothesized to provide
he proliferative signal during Moloney MCF-mediated
ymphomagenesis. The autocrine loop involves not only
pregulation of IL-9 expression in tumor cells but also
ctivation of the IL-9R locus secondary to proviral inser-
ion. The Moloney MCF envelope protein is implicated in
he establishment of this autocrine loop and therefore is
ypothesized to act as an autocrine growth factor for
oloney MuLV-induced lymphomas (Flubacher et al.,
994). An envelope-mediated IL-9 autocrine loop is ap-
arently not involved in SL3- or FS-induced tumors be-
FIG. 7. . RT–PCR analysis of IL-10 mRNA in the spleen and thymus of
L3-infected animals (SL3) collected at 1, 2, 4, or 8 weeks p.i. and in
ge-matched uninfected controls (UC). Specific primer sets were used
o amplify IL-10 mRNA or GAPDH mRNA. Amplification conditions were
elected such that the reaction was monitored outside the plateau
hase. The results from analysis of three animals at each timepoint are
hown. Also shown are a reagent control from which cDNA template
as omitted (2), and a positive control that included cDNA from
HA-stimulated mouse spleen cells (1). ND, not done.
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259CYTOKINES IN MuLV-MEDIATED LYMPHOMASause IL-9 is not expressed and the IL-9R locus is
resent in germline configuration (data not shown).
The absence of IL-2 mRNA is significant not only from the
oint of view of proliferative signaling but also because of
ts major role in augmenting cell-mediated immune re-
ponses, e.g., cytotoxic T-lymphocyte activity and macro-
hage activation (Levy and Bost, 1996). Consistent with this
inding are the relatively low levels of mRNA for IFNg (Fig.
), another major effector of cell-mediated immune re-
ponses (Levy and Bost, 1996). In the absence of IL-2 and
FNg, it is unlikely that cell-mediated antitumor immune
esponses would be optimal.
RT–PCR analyses of end-stage lymphomas further reveal
igh levels of mRNA-encoding Th2 cytokines, IL-4, and
L-10 (Fig. 1). IL-10 in the tumor environment may exert a
trongly immunosuppressive influence by (i) limiting the
roduction of cytokines that augment cell mediated immu-
ity (i.e., IL-12, IFNg, and IL-2), (ii) limiting the activity of
umoricidal macrophages, and (iii) skewing the overall im-
une response toward production of nonprotective anti-
odies. The net effect would be to augment antibody pro-
uction rather than promoting an efficacious cell-mediated
mmune response (Levy and Bost, 1996). Others have hy-
othesized that these functions of IL-10 suppress an effec-
ive antitumor immune response directed against B-cell
umors (Bost et al., 1995; Pyeon et al., 1996) or bladder
umors (Halak et al., 1999) in experimental animals and
gainst human melanomas, basal cell carcinomas, and
quamous cell carcinomas (Chen et al., 1994; Kim et al.,
995). The presence of IL-4 and IL-10 simultaneously is
ikely to be particularly potent because the cytokines syn-
rgize in their immunosuppressive effects. Synergy has
een demonstrate in suppressing T-cell function or prolif-
ration, and in inhibiting the ability of IFNg to activate
acrophages (Sher et al., 1992).
RT–PCR analysis of end-stage lymphomas (Fig. 1)
emonstrates the profile of cytokine mRNA present in the
umor environment but does not indicate the cellular
ource of those cytokines. To evaluate the possibility that
he cytokines observed are products of tumor cells, we
xamined the patterns of cytokine mRNA expressed in
umor-derived cell lines induced by SL3 or closely re-
ated retroviruses. These studies showed that, in gen-
ral, the cytokine mRNA profiles detected in end-stage
ymphomas are recapitulated in tumor-derived cell lines
xpressing ecotropic, SL3-like virus (Fig. 2). These find-
ngs suggest that the profile of cytokines observed in
ymphomas may be generated substantively by tumor
ells. Spleen and thymus from age-matched, uninfected
IH/Swiss mice were examined further to evaluate the
ossibility that the developing tumor may actively modify
he immune response in its immediate environment
hrough the expression of cytokines. Some differences in
ytokine gene expression were evident in comparing
umors and age-matched control tissues, most notably in
he levels of IFNg mRNA. IFNg mRNA is readily detected sn the spleen and thymus of most control animals, al-
hough its expression in tumors is significantly lower
Fig. 3). As discussed above, a downregulation in expres-
ion of IFNg is predicted to support tumor development
y diminishing an effective cell-mediated immune re-
ponse. In general, however, the profile of cytokines
xpressed in normal spleen and thymus was seen to
esemble that in tumor-bearing tissues (Fig. 3), most
mportantly regarding the absence of IL-2 mRNA and the
resence of IL-10 mRNA. Thus the immune environment
n the target tissue may be hospitable to the developing
umor and, indeed, may influence the selection of tissue
n which the lymphoma develops.
To evaluate that possibility, the expression of IL-2,
FN-g, and IL-10 mRNA was studied in spleen and thy-
us longitudinally during infection with SL3. Endoge-
ous expression of IL-10 mRNA was clearly evident in
issues of infected and uninfected animals, beginning at
2 weeks of age (Fig. 7). Because IL-10 is predicted to
uppress an efficacious cell-mediated immune re-
ponse, its endogenous expression indeed may provide
hospitable immune environment for the establishment
f viral infection and/or malignancy. Further striking is
he observation that IFN-g mRNA clearly increases in
L3-infected tissues at early times after infection, sug-
esting that the host does mount a cell-mediated im-
une response to infection (Fig. 6). It is clear, however,
hat virus infection is not cleared by this early response
Fig. 4). The mechanisms by which SL3-infected cells
ay escape immune recognition and destruction remain
nknown. A potential mechanism is suggested by recent
tudies in which the ability of C57BL/6 mice to generate
CTL response to AKR/Gross MuLV-induced tumor cells
as measured with or without SL3 infection before im-
une priming. The studies show that infection with SL3
efore priming with MuLV-positive tumor cells profoundly
nhibited the subsequent virus-specific CTL response,
hus suggesting a mechanism by which the virus may
vade immune surveillance (Coppola et al., 1996). It is
ot yet known whether the influence of SL3 infection on
he generation of specific, antiviral CTL responses is
ytokine mediated.
The pattern of cytokine mRNA observed in infected
issues and lymphomas is similar to that seen in tissues
nfected with other retroviruses (Gazzinelli et al., 1992;
lerici and Shearer, 1993; Faxvaag et al., 1993, 1995; Lee
t al., 1995; Pyeon et al., 1996). In peripheral blood mono-
uclear cells from bovine leukemia virus-infected ani-
als, for example, disease progression is associated
ith increased expression of IL-10 mRNA and decreased
xpression of IL-2 and IFNg mRNA (Pyeon et al., 1996). A
imilar pattern is observed during the progression of
isease induced by nononcogenic, immunosuppressive
etroviruses in humans and in animal models. For exam-
le, the spontaneous production of cytokines from
pleen cells has been measured in mice infected with
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260 BEATY ET AL.P-BM5 MuLV, a mixture of viruses that induces mouse
IDS (MAIDS). When examined during chronic infection,
uch cells produce low levels of IL-2 and IFNg and
igher levels of IL-4, IL-10, and other Th2 cytokines
Gazzinelli et al., 1992). Human peripheral blood mono-
uclear cells collected after prolonged HIV infection also
xpress predominantly Th2 cytokines in response to viral
ntigens. In particular, such cells express low levels of
L-2 and IFNg and increased levels of IL-4 and IL-10
Clerici and Shearer, 1993). These similarities among
isparate retroviral diseases suggest that active retrovi-
al infection per se may represent a major determinant of
he cytokines expressed in MuLV-induced lymphomas. In
his respect, it is noteworthy that the TM transmembrane
rotein of MuLV and other mammalian leukemia viruses
s thought to be immunosuppressive in itself. For exam-
le, addition of a synthetic TM-derived peptide to mito-
en-stimulated peripheral blood mononuclear cells aug-
ented the expression of IL-10 mRNA and inhibited
xpression of IFNg mRNA (Haraguchi et al., 1995). Thus
ctive retroviral replication in the target tissue for tumor
evelopment may influence the high levels of Th2 cyto-
ines, and low levels of Th1 cytokines, observed in end-
tage lymphomas.
Although the focus of the present study is on the
attern of Th1 or Th2 cytokines expressed during the
ourse of MuLV infection, it is clear that the cytokine
esponse to retroviral infection is considerably more
omplex. For example, innate cytokine responses are
lso significant mediators of retroviral infection, includ-
ng particularly IFN-alpha (Biron, 1998). A recent study of
nimals infected with Rous sarcoma virus showed that
he administration of chicken IFN-alpha inhibited tumor
evelopment in a manner dependent on its intrinsic an-
iviral activity (Plachy et al., 1999). Costimulatory mole-
ules, known to modulate interactions between immune
ells, also are implicated both in pathogenesis and in
enerating protective immune responses during retrovi-
al infection. For example, although a Th2-like cytokine
attern is induced during LP-BM5 MuLV infection and
ay be associated with progression of MAIDS, it is clear
hat signaling through the CD40 costimulatory pathway
s essential for the development of MAIDS-associated
ymphoproliferation (Gazzinelli et al., 1992; van Essen et
l., 1995; Green et al., 1996; Yu et al., 1999). The potential
ole of Th1- or Th2-type cytokines in modulating retroviral
ncogenesis, as discussed in the present report, must
e viewed in the context of the intact immune response
f an otherwise healthy animal.
MATERIALS AND METHODS
issues and cell lines
End-stage lymphomas were collected from NIH/Swiss
ice inoculated as newborns with SL3–3 MuLV (SL3) or
ith FS-LC MuLV (FS), a recombinant MuLV in which the m3 region of SL3 was replaced with that of a T-cell
ymphoma-derived FeLV provirus. Animals were inocu-
ated intraperitoneally with 103 XC PFU in 0.1ml of culture
upernatant from productively infected fibroblasts, con-
itions under which both SL3 and FS induce lymphomas
f T-cell origin. The tumors involve thymus, lymph nodes,
nd spleen and occur with a mean latency of 71 days in
he case of SL3 infection or 90 days in the case of FS
nfection (Pantginis et al., 1997). Tissues also were col-
ected from age-matched, uninfected NIH/Swiss mice as
ontrols. Four cell lines derived from spontaneous T-cell
ymphomas of AKR mice were examined, i.e., SL3H,
L7H, SL11H, and MCF247I. These cell lines produce
L3 or a closely related ecotropic MuLV (SL3H, SL7H) or
roduce recombinant viruses with polytropic env genes
SL11H, MCF247I) (Pedersen et al., 1982). For longitudi-
al studies, neonatal (1–2 days old) NIH/Swiss mice
ere inoculated intraperitoneally with 1000 XC plaque-
orming units of SL3–3 MuLV in 0.1 ml volume. At various
imes after inoculation (1, 2, 4, and 8 weeks), the spleen
nd thymus were collected from infected animals and
nap-frozen. As controls, tissues also were collected
rom age-matched uninfected animals.
solation of RNA and RT–PCR of cytokine mRNA
Total cellular RNA was isolated from tissues and cell
ines by guanidinium isothiocyanate extraction and ce-
ium chloride density gradient ultracentrifugation (Aus-
bel, 1987). Contaminating genomic DNA then was re-
oved by treatment with RNase-free DNase (1 U/mg
NA; Boehringer-Mannheim, Indianapolis, IN) for 15 min
t 37°C in a buffer comprised of 20 mM Tris pH 8.4, 50
M KCl, and 1.5 mM MgCl2. The enzyme was removed
y repeated organic extraction followed by ethanol pre-
ipitation. Total cellular RNA (5 mg) was reverse tran-
cribed in the presence of 50 nmoles random hexamers
sing 200 U of RNase H2 Moloney leukemia virus re-
erse transcriptase (Superscript II; Life Technologies,
aithersburg, MD) as previously described (Kincy-Cain
nd Bost, 1996). Polymerase chain amplification reac-
ions then were performed using primers specific for the
RNA encoding each cytokine of interest. The amplifi-
ation reaction contained ;10% of the total cDNA, 100 ng
ach specific primer, 2 mM MgCl2, 0.2 mM each deoxyri-
onucleoside triphosphate, 2.5 U Taq DNA polymerase
romega, Madison, WI), and a reaction buffer provided
y the manufacturer in a total volume of 100 ml. Amplifi-
ation was performed as previously described (Bost et
l., 1995; Chong et al., 1996) in a thermocycler (Robocy-
ler 40; Stratagene, La Jolla, CA) using 95°C denatur-
tion, 58°C annealing, and 72°C extension temperatures
or 28 cycles, the first three of which had extended
enaturation and annealing times. Positive controls for
T–PCR included the amplification of each cytokine
RNA from PHA-stimulated mononuclear cells from
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261CYTOKINES IN MuLV-MEDIATED LYMPHOMASouse spleen. As a further control, GAPDH mRNA was
mplified from the cDNA of each lymphoma. The ampli-
ication of GAPDH mRNA served as a control for the
ntegrity of cDNA and allowed for the subsequent allo-
ation of approximately equivalent amounts of cDNA for
ach cytokine amplification reaction. GAPDH and cyto-
ine mRNA amplification reactions were tested further to
nsure that the number of cycles used remained outside
he reaction plateau, i.e., within the increasing range of
mplification. This test consisted of a visual sampling of
he progress of each amplification reaction between 20
nd 40 cycles. Thus the assay for cytokine mRNA was
emiquantitative because the amount of cDNA used in
ach amplification reaction was normalized to yield com-
arable signal upon amplification of GAPDH mRNA and
ecause reaction parameters were selected for detec-
ion outside the reaction plateau. Negative controls for
T–PCR included parallel amplification reactions lacking
everse transcriptase or lacking cDNA template. Ampli-
ication products were visualized by agarose gel electro-
horesis. Examination of each cytokine mRNA from each
ample was performed at least three times. Primer pairs
or the amplification of IL-2, IL-4, IL-10, IFN-g, and
APDH mRNA have been described previously (Bost et
l., 1995; Kincy-Cain and Bost, 1996; Marriott and Bost,
998). Positive- and negative-strand primers used to am-
lify IL-9 mRNA were as follows (283-bp product):
9GAAGGATGATCCACCGTCAAAATGC and 59CGTC-
CCAGGAGACTCTTCAGAAATG, respectively (Van Snick
t al., 1989).
solation of genomic DNA and Southern blot analysis
Large molecular weight DNA was isolated from lym-
homas, and Southern blot analysis was performed as
reviously described (Athas et al., 1995). The IL-9R locus
as examined using an IL-9R cDNA probe (Renauld et
l., 1992).
CR amplification of SL3 proviral DNA
Genomic DNA from spleen and thymus of SL3-infected
nd uninfected NIH-Swiss mice was isolated using the
IAamp Tissue Kit (Qiagen, Inc.) as described by the
anufacturer. DNA yield was quantified spectrophoto-
etrically, and 1 mg of genomic DNA from each sample
as used in PCR amplification reactions to detect SL3
roviral DNA. Oligonucleotide primers specific for the
L3 LTR were as follows: SL3a (59CTTCATAAGGCT-
AGCCAGCTAACTGCAG39) and SL3c (59CCAGAAACT-
TCTCAAGGTT39). Amplification reaction conditions
ere as follows: 95°C for 5 min followed by the addition
f Taq polymerase, followed by 30 cycles of 94°C for 1
in, 54°C for 1 min, and 72°C for 1 min, with a final
xtension of 10 min at 72°C. The product of amplification,
redicted to be 346 nucleotides, was visualized by aga-ose gel electrophoresis. Nucleotide sequence of theroduct was verified. As a positive control for the pres-
nce of amplifiable DNA, parallel reactions were con-
ucted using primers for the GAPDH gene.
ACKNOWLEDGMENTS
The authors gratefully acknowledge the assistance of Christal Bow-
an with studies of the IL-9R locus in tumor DNA. This work was
upported by grants from the American Cancer Society (RPG-94–012-
4-VM) and the Ladies Leukemia League to L.S.L. and by Development
unds of the Tulane Cancer Center. J.L. was supported by National
nstitutes of Health Grants CA-44822 and CA-57337. J.P. was supported
y NIH Training Grant CA-09060.
REFERENCES
thas, G. B., Choi, B., Prabhu, S., Lobelle-Rich, P. A., and Levy, L. S.
(1995). Genetic determinants of feline leukemia virus-induced multi-
centric lymphomas. Virology 214, 431–438.
thas, G. B., Starkey, C. R., and Levy, L. S. (1994). Retroviral determi-
nants of leukemogenesis. Crit. Rev. Oncog. 5, 169–199.
usubel, F. M. (1987). “Current Protocols in Molecular Biology.” J. Wiley,
New York.
iron, C. A. (1994). Cytokines in the generation of immune responses to,
and resolution of, virus infection. Curr. Opin. Immunol. 6, 530–538.
iron, C. A. (1998). Role of early cytokines, including alpha and beta
interferons (IFN- alpha/beta), in innate and adaptive immune re-
sponses to viral infections. Semin. Immunol. 10, 383–390.
ost, K. L., Bieligk, S. C., and Jaffe, B. M. (1995). Lymphokine mRNA
expression by transplantable murine B lymphocytic malignancies.
Tumor-derived IL-10 as a possible mechanism for modulating the
anti-tumor response. J. Immunol. 154, 718–729.
hen, Q., Daniel, V., Maher, D. W., and Hersey, P. (1994). Production of
IL-10 by melanoma cells: Examination of its role in immunosuppres-
sion mediated by melanoma. Int. J. Cancer 56, 755–760.
hong, C., Bost, K. L., and Clements, J. D. (1996). Differential production
of interleukin-12 mRNA by murine macrophages in response to
viable or killed Salmonella spp. Infect. Immun. 64, 1154–1160.
lerici, M., and Shearer, G. M. (1993). A TH13TH2 switch is a critical
step in the etiology of HIV infection. Immunol. Today 14, 107–111.
oppola, M. A., Green, W. R., and Rich, R. F. (1996). Impaired generation
of anti-AKR/Gross murine leukemia virus cytotoxic T lymphocytes in
mice experimentally infected with MuLV. Viral Immunol. 9, 107–119.
ortes, J., and Kurzrock, R. (1997). Interleukin-10 in non-Hodgkin’s
lymphoma. Leuk. Lymphoma 26, 251–259.
an, H. (1997). Leukemogenesis by Moloney murine leukemia virus: A
multistep process. Trends Microbiol. 5, 74–82.
axvaag, A., Espevik, T., and Dalen, A. (1993). Multiple derangements of
cytokine homeostasis in mice infected with immunosuppressive ret-
rovirus. Cell Immunol. 150, 247–256.
axvaag, A., Espevik, T., and Dalen, A. (1995). An immunosuppressive
murine leukaemia virus induces a Th13Th2 switch and abrogates
the IgM antibody response to sheep erythrocytes by suppressing the
production of IL-2. Clin. Exp. Immunol. 102, 487–495.
lubacher, M. M., Bear, S. E., and Tsichlis, P. N. (1994). Replacement of
interleukin-2 (IL-2)-generated mitogenic signals by a mink cell focus-
forming (MCF) or xenotropic virus-induced IL-9- dependent autocrine
loop: Implications for MCF virus-induced leukemogenesis. J. Virol.
68, 7709–7716.
azzinelli, R. T., Makino, M., Chattopadhyay, S. K., Snapper, C. M., Sher,
A., Hugin, A. W., and Morse, H. C. (1992). CD41 subset regulation in
viral infection. Preferential activation of Th2 cells during progression
of retrovirus-induced immunodeficiency in mice. J. Immunol. 148,
182–188.
reen, K. A., Crassi, K. M., Laman, J. D., Schoneveld, A., Strawbridge,
R. R., Foy, T. M., Noelle, R. J., and Green, W. R. (1996). Antibody to the
HH
H
H
K
K
K
L
L
M
M
P
P
P
P
R
R
R
S
S
v
V
V
W
W
Y
262 BEATY ET AL.ligand for CD40 (gp39) inhibits murine AIDS-associated splenomeg-
aly, hypergammaglobulinemia, and immunodeficiency in disease-
susceptible C57BL/6 mice. J. Virol. 70, 2569–2575.
alak, B. K., Maguire, H. C., and Lattime, E. C. (1999). Tumor-induced
interleukin-10 inhibits type 1 immune responses directed at a tumor
antigen as well as a non-tumor antigen present at the tumor site.
Cancer Res. 59, 911–917.
araguchi, S., Good, R. A., James-Yarish, M., Cianciolo, G. J., and Day,
N. K. (1995). Differential modulation of Th1- and Th2-related cytokine
mRNA expression by a synthetic peptide homologous to a conserved
domain within retroviral envelope protein. Proc. Natl. Acad. Sci. USA
92, 3611–3615.
e, Y. W., and Malek, T. R. (1998). The structure and function of gamma
c-dependent cytokines and receptors: Regulation of T lymphocyte
development and homeostasis. Crit. Rev. Immunol. 18, 503–524.
su, S. M., Waldron, J. W., Jr., Hsu, P. L., and Hough, A. J., Jr. (1993).
Cytokines in malignant lymphomas: Review and prospective evalu-
ation. Hum. Pathol. 24, 1040–1057.
im, J., Modlin, R. L., Moy, R. L., Dubinett, S. M., McHugh, T., Nickoloff,
B. J., and Uyemura, K. (1995). IL-10 production in cutaneous basal and
squamous cell carcinomas. A mechanism for evading the local T cell
immune response. J. Immunol. 155, 2240–2247.
incy-Cain, T., and Bost, K. L. (1996). Increased susceptibility of mice to
Salmonella infection following in vivo treatment with the substance P
antagonist, spantide II. J. Immunol. 157, 255–264.
irman, I., Vainer, B., and Nielsen, O. H. (1998). Interleukin-15 and its
role in chronic inflammatory diseases. Inflamm. Res. 47, 285–289.
ee, J. S., Giese, N. A., Elkins, K. L., Yetter, R. A., Holmes, K. L., Hartley,
J. W., and Morse, H. C., 3rd. (1995). Effects of exogenous, nonleuke-
mogenic, ecotropic murine leukemia virus infections on the immune
systems of adult C57BL/6 mice. J. Virol. 69, 4182–4188.
evy, L. S., and Bost, K. L. (1996). Mechanisms that contribute to the
development of lymphoid malignancies: Roles for genetic alterations
and cytokine production. Crit. Rev. Immunol. 16, 31–57.
arriott, I., and Bost, K. L. (1998). Substance P diminishes lipopolysac-
charide and interferon-gamma-induced TGF-beta 1 production by
cultured murine macrophages. Cell Immunol. 183, 113–120.
arshall, D. J., and Gaulton, G. N. (1996). The role of the immune
response in MULV-induced lymphomagenesis. Leukemia 10, 1860–
1866.
antginis, J., Beaty, R. M., Levy, L. S., and Lenz, J. (1997). The feline
leukemia virus long terminal repeat contains a potent genetic deter-
minant of T-cell lymphomagenicity. J. Virol. 71, 9786–9791.
edersen, F. S., Crowther, R. L., Hays, E. F., Nowinski, R. C., and
Haseltine, W. A. (1982). Structure of retroviral RNAs produced by cell
lines derived from spontaneous lymphomas of AKR mice. J. Virol. 41,
18–29.lachy, J., Weining, K. C., Kremmer, E., Puehler, F., Hala, K., Kaspers, B.,
and Staeheli, P. (1999). Protective effects of type I and type II inter-
ferons toward Rous sarcoma virus-induced tumors in chickens. Vi-
rology 256, 85–91.
yeon, D., O’Reilly, K. L., and Splitter, G. A. (1996). Increased interleu-
kin-10 mRNA expression in tumor-bearing or persistently lymphocy-
totic animals infected with bovine leukemia virus. J. Virol. 70, 5706–
5710.
enauld, J. C., Druez, C., Kermouni, A., Houssiau, F., Uyttenhove, C., Van
Roost, E., and Van Snick, J. (1992). Expression cloning of the murine
and human interleukin 9 receptor cDNAs. Proc. Natl.Acad. Sci USA
89, 5690–5694.
enauld, J. C., van der Lugt, N., Vink, A., van Roon, M., Godfraind, C.,
Warnier, G., Merz, H., Feller, A., Berns, A., and Van Snick, J. (1994).
Thymic lymphomas in interleukin 9 transgenic mice. Oncogene 9,
1327–1332.
enauld, J. C., Vink, A., Louahed, J., and Van Snick, J. (1995). Interleu-
kin-9 is a major anti-apoptotic factor for thymic lymphomas. Blood 85,
1300–1305.
arzotti, M., Robbins, D. S., and Hoffman, P. M. (1996). Induction of
protective CTL responses in newborn mice by a murine retrovirus.
Science 271, 1726–1728.
her, A., Gazzinelli, R. T., Oswald, I. P., Clerici, M., Kullberg, M., Pearce,
E. J., Berzofsky, J. A., Mosmann, T. R., James, S. L., and Morse, H. C.
(1992). Role of T-cell derived cytokines in the downregulation of
immune responses in parasitic and retroviral infection. Immunol. Rev.
127, 183–204.
an Essen, D., Kikutani, H., and Gray, D. (1995). CD40 ligand-transduced
co-stimulation of T cells in the development of helper function.
Nature 378, 620–623.
an Snick, J., Goethals, A., Renauld, J. C., Van Roost, E., Uyttenhove, C.,
Rubira, M. R., Moritz, R. L., and Simpson, R. J. (1989). Cloning and
characterization of a cDNA for a new mouse T cell growth factor
(P40). J. Exp. Med. 169, 363–368.
ink, A., Renauld, J. C., Warnier, G., and Van Snick, J. (1993). Interleu-
kin-9 stimulates in vitro growth of mouse thymic lymphomas. Eur.
J. Immunol. 23, 1134–1138.
aldmann, T., Tagaya, Y., and Bamford, R. (1998). Interleukin-2, inter-
leukin-15, and their receptors. Int. Rev. Immunol. 16, 205–226.
ojtowicz-Praga, S. (1997). Reversal of tumor-induced immunosup-
pression: A new approach to cancer therapy. J. Immunother. 20,
165–177.
u, P., Morawetz, R. A., Chattopadhyay, S., Makino, M., Kishimoto, T.,
and Kikutani, H. (1999). CD40-deficient mice infected with the defec-
tive murine leukemia virus LP-BM5def do not develop murine AIDS
but produce IgE and IgG1 in vivo. Eur. J. Immunol. 29, 615–625.
